Over 1,006 Vaccine Adverse Reactions in Three Days... 8 Additional Death Reports, Causality Unconfirmed

[Image source=Reuters Yonhap News]

[Asia Economy Reporter Yuri Kim] The number of reported adverse reactions following COVID-19 vaccination in South Korea increased by 1,006 cases over three days. Since vaccinations began on February 26, the total number of suspected adverse reaction reports has reached 24,130.

According to the COVID-19 Vaccination Response Promotion Team on the 22nd, 1,006 new cases of adverse reactions were reported to health authorities between the 19th and 21st of this month after receiving the vaccine.

There were 8 additional death reports: 3 on the 20th and 5 on the 21st. Causality has not been confirmed. Among the deceased, 7 had received the Pfizer vaccine, and 1 had received the AstraZeneca (AZ) vaccine. Nine new suspected cases of anaphylaxis, a severe systemic allergic reaction, were reported, 8 of which occurred in Pfizer vaccine recipients. There were 75 new reports of major adverse reactions, including 'special interest adverse reactions,' ICU admissions, life-threatening conditions, permanent disabilities, and sequelae. The remaining 914 cases involved common post-vaccination symptoms such as muscle pain, headache, fever, chills, and nausea.

The total 24,130 suspected adverse reaction reports represent approximately 0.44% of the 5,495,098 cumulative first and second dose vaccinations administered domestically. Reports related to the AstraZeneca vaccine number 18,513, while those related to the Pfizer vaccine number 5,617.

The adverse reaction reporting rate relative to cumulative vaccinations is about 0.81% for AstraZeneca and 0.17% for Pfizer. Death reports following vaccination total 148 (88 Pfizer, 60 AstraZeneca). Including cases initially reported with other symptoms that later worsened to death, the total is 201. Suspected anaphylaxis cases total 209 (154 AstraZeneca, 55 Pfizer), and major adverse reaction cases total 765 (401 AstraZeneca, 364 Pfizer).

Of all adverse reaction reports, 95.3%, or 23,008 cases, are relatively mild symptoms commonly occurring after vaccination, such as muscle pain, headache, fever, chills, and nausea.

Meanwhile, as of midnight on the 22nd, 13,674 people received their first vaccine dose. This brings the total number of people who have completed the first dose to 3,787,570. Among them, 2,061,032 received the AstraZeneca vaccine, and 1,726,538 received the Pfizer vaccine. The number of new second dose vaccinations was 221,916, bringing the total number of people who have completed the second dose to 1,707,528.

This content was produced with the assistance of AI translation services.